Cel Sci Corporation (CVM)

[drkazmd65]

Right on the mark with this point FM:

The nature of the beast is that with the 7-8 months of inactivity caused by the hold more "events" occurred so they are close to their goal...

At this point anybody who was enrolled and treated prior to May 2014 is a 'harvestable data point', whether they died or whether they survived through the full three years post-treatment.

That means (for good or ill) everybody that the old CRO enrolled is through the clinical trail and assessment period.

The 70+ or so patients that our new CROs enrolled in early 2014 through May 1, 2014 are now (for good or ill) through the clinical trail and assessment period.

The new CROs enrolled ~190 patients during 2014 - all of whom should be through the clinical trial and assessment period by end of 2017.

The ~340 patients the new CROs enrolled during 2015 will all similarly pass through that clinical trial and assessment period during the next year of 2018.

But also a good point - the Arbitration might seem less likely to have a huge payout if the damage has been somewhat minimized by NOT excluding the Inventiv-enrolled patients outright. Then it primarily becomes a time-delay issue by not ramping up enrollment effectively rather than in screwing up part of the study population itself.

I really do hope we hear something about the Arbitration before the end of the quarter here,... one way or the other - at least that end of the company's issues is resolved.